President & Chief Executive Officer
Joe Henein is a senior Pharma executive with a career extending over 30 years in big Pharma, covering many geographies including; USA, Europe, and the Middle East. Formerly, Joe served as the Managing Director of Wyeth Pharmaceuticals for the Middle East and North Africa (MENA), VP Strategic Marketing and Global Commercial Chair for a number of therapeutic areas, most notably infectious diseases, and the Therapeutic Area Head for Women’s Health Care. He has also assumed a number of senior managerial roles in American Cyanamid and Merrill Dow and served in various corporate and industry committees; including PhRMA MEAC as the Vice Chair and the Chair for the PhRMA MEAC Ethics Review Board. Joe is a frequent speaker in pharmaceutical congresses including compliance forums. Joe holds a PharmD. Degree.
Chief Financial Officer
Rida AlGhoul joined NewBridge as Chief Financial Officer in April 2018. Rida holds a Bachelor’s Degree in Economics and Statistics from the University of Jordan and a Masters in Financial Economics from the Hashemite University in Jordan. He commenced his employment in the world of banking where he held Operational and Commercial and Credit & Risk managerial roles with the Arab Bank in Jordan. He moved to Hikma Pharmaceuticals in 2003 and rose to the position of MENA CFO and Vice president for MENA Finance & Operations, including holding a seat on the Board of 7 of Hikma’s subsidiaries. In 2012, Reda moved from Hikma to take on the role of CEO of the Hawkary Group, based in Iraq and was responsible for the successful implementation of an accelerated growth strategy for the Group.
Baher Massoud, M.D.
Chief Medical Officer
Dr. Baher Massoud joined NewBridge in October 2013. Formerly, Baher served as the Regional Head, Medical & Clinical Affairs at Pfizer MEA where he also chaired the Regional medical council, which included Medical Affairs, Drug safety, Medinfo, Clinical Research, Health Outcomes (HEOR), QA & Regulatory, and supervised the Regional therapeutic & Country Medical Affairs teams across Africa and Middle East countries. Baher served as a member of both Pfizer Regional Leadership team in Dubai as well as Global Medical Affairs leadership team in New York. Previously, he held the role of Area Medical Officer and CR&D Regional Director for Wyeth MENA, leading the Medical Affairs function as well as Wyeth’s CR&D operations in the region. Earlier, he worked with Eli Lilly in the region. Prior to this Baher was Associate Professor of Internal Medicine & Endocrinology at Ain-Shams University - Cairo, Egypt.
Vice President Human Resources and Legal
Vanessa Edmunds joined NewBridge Pharmaceuticals in May 2013. Vanessa is a UK qualified employment lawyer and has lived and worked in the Middle East for the last 15 years. In addition, Vanessa has over 10 years’ experience in the pharmaceutical industry having held senior regional HR leadership roles with Wyeth Pharmaceuticals, Pfizer and Baxter Healthcare handling all aspects of human resource management across multiple jurisdictions in the Middle East and Africa Region. Vanessa holds an LLB Degree.
General Manager Saudi Arabia
Tarek Safwat joined NewBridge in April 2018 as General Manager Saudi Arabia. Tarek has over 24 years’ experience in Pharmaceuticals in the Middle East and has worked for over 20 years’ in the Kingdom of Saudi Arabia. Prior to joining NewBridge, Tarek worked for Eli Lilly in Saudi Arabia and during this time held a number of senior commercial and market access roles, including Market Access Director, KSA. Throughout his career, Tarek has built a very strong business network in the Kingdom and has gained significant knowledge and expertise to identify market access opportunities resulting in exceptional growth in market share and achievement of significant business success.
Director Strategy and Commercial Operations
Rosie is a Chartered Accountant who joined NewBridge in July 2013. She has over 10 years’ experience in multi-nationals covering both Pharmaceuticals and FMCG in Africa, Middle East, Australia and New Zealand and most recently headed up the Gulf Finance division for PepsiCo International in Dubai. Rosie started her career with PricewaterhouseCoopers Australia as an auditor. Following this, Rosie assumed positions in Senior Commercial Finance with Wyeth Australia and Senior Finance Manager for Pfizer in Dubai for AFME region.
Misan Abu Rmaileh
Business Development Director
Misan Abu Rmaileh joined NewBridge in November 2010 and has 12 years of experience in the Pharmaceutical industry. She started her career at Hikma Pharmaceuticals in Business Development and progressed to the position of Senior BD associate for the MENA Region before moving to Aspen Dubai as MENA Business Development Manager. Misan holds a Bachelor’s degree in Pharmacy.
Senior Business Unit Director Neuroscience
Ahmed Saeed joined NewBridge as the Senior Business Unit Director for Neuroscience in January 2017. Ahmed has over 20 years’ experience in Pharmaceuticals in the Region, having worked previously in senior leadership roles in both commercial and marketing for in the Biologics, Immunology and RA therapeutic areas in the MENA region.
With a background in Veterinary Science, Ahmed has a proven track record of building high performing teams and achievement of business results and growth of market share. He started his career in commercial in Egypt, and later moved to the Gulf to work for Wyeth Pharmaceuticals, and during his tenure, held numerous senior marketing and commercial roles in the MENA region.
Hisham El Sayed
Business Unit Director Immunology
Hisham has more than 16 years of Pharmaceutical experience. After 12 years with Wyeth & Pfizer Pharmaceuticals, where he held positions in both the Sales & Medical Departments and held the role of the Regional Medical ACT of Enbrel for the MEA Region with Pfizer, he moved and joined NewBridge in November 2012.
His roles and responsibilities throughout his career have allowed him to work in various therapeutic areas such as Biologics, Vaccines, Anti-infective & Transplantation on both international and regional scopes. Hisham has worked in different capacities with a broad understanding of corporate cultures and leadership skills involving managing, developing and motivating teams.
Hisham holds a Doctor of Medicine (MD) Degree from the Faculty of Medicine, Mansoura University (1999). In his current role of Business Unit Director at NBP, he heads the Sales and Marketing of the Immunology team, and is responsible for achieving the defined P&L and financial metrics for the BU.
Business Unit Director Oncology
Hesham Fathy joined NewBridge in July 2011, and has held various leadership roles in both commercial and medical functions over the past 7 years. He has over 17 years’ industry experience, gained in Egypt, the Gulf and Saudi Arabia. Before joining NewBridge, Hesham held the role of Medical Advisor for Merck Sharp Dohme, managing medical affairs for the Oncology line across the ME Region. He previously worked as Senior Oncology Business Coordinator for Schering-Plough Gulf Region. Throughout his career, Hesham has worked extensively in the areas of Oncology and Hematology. Hesham holds a Bachelor degree in Clinical Pharmacy from Tanta University, Egypt.